Search research articles
Contact Us
Filters
Showing results (51-60 of 53) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 53 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 7, 2018
Engaging Patients in Setting a Patient-Centered Outcomes Research Agenda in Hematopoietic Cell Transplantation
Linda J Burns, Beatrice Abbetti, Stacie D Arnold, et al.
Journal of Medicinal Chemistry
|
May 24, 2008
Indole cytosolic phospholipase A2 alpha inhibitors: discovery and in vitro and in vivo characterization of 4-{3-[5-chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propyl}benzoic acid, efipladib
John C McKew, Katherine L Lee, Marina W H Shen, et al.
Journal of Medicinal Chemistry
|
May 13, 2017
Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design
Katherine L Lee, Catherine M Ambler, David R Anderson, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 53) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 53 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 7, 2018
Engaging Patients in Setting a Patient-Centered Outcomes Research Agenda in Hematopoietic Cell Transplantation
Linda J Burns, Beatrice Abbetti, Stacie D Arnold, et al.
Journal of Medicinal Chemistry
|
May 24, 2008
Indole cytosolic phospholipase A2 alpha inhibitors: discovery and in vitro and in vivo characterization of 4-{3-[5-chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propyl}benzoic acid, efipladib
John C McKew, Katherine L Lee, Marina W H Shen, et al.
Journal of Medicinal Chemistry
|
May 13, 2017
Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design
Katherine L Lee, Catherine M Ambler, David R Anderson, et al.
Page
of 6